Literature DB >> 28333128

A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.

Job van der Palen, Mike Thomas, Henry Chrystyn, Raj K Sharma, Paul Dlpm van der Valk, Martijn Goosens, Tom Wilkinson, Carol Stonham, Anoop J Chauhan, Varsha Imber, Chang-Qing Zhu, Henrik Svedsater, Neil C Barnes.   

Abstract

Entities:  

Year:  2017        PMID: 28333128      PMCID: PMC5375387          DOI: 10.1038/npjpcrm.2017.1

Source DB:  PubMed          Journal:  NPJ Prim Care Respir Med        ISSN: 2055-1010            Impact factor:   2.871


× No keyword cloud information.
Correction to: npj Primary Care Respiratory Medicine (2016) 26, 16079; doi:10.1038/npjpcrm.2016.79; published online 24 November 2016 In the original version of the article, there were typographical errors that have been corrected in the html and pdf versions of the article. On page 2, column 1, under Results, ‘Caucasian (98%)’ was replaced with ‘Caucasian (>99%)’; in Table 2, mean age in total population ‘48.6 (17.8)’ was replaced with ‘46.3 (17.9)’; and in Table 4, ‘Did not hold device upright (±45%) during dose preparation’ was replaced with ‘Did not hold device upright (±45°) during dose preparation’. On page 4, column 1, under ‘COPD patients’, the text ‘all P<0.001’ was deleted.
  3 in total

1.  Correct use and ease of use of a placebo dry powder inhaler in subjects with asthma and chronic obstructive pulmonary disease.

Authors:  Gregory J Feldman; Dmitry V Galkin; Pinal Patel; Kathryn A Collison; Raj Sharma
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

2.  Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design.

Authors:  Sally Worsley; Neil Snowise; David M G Halpin; Dawn Midwinter; Afisi S Ismaila; Elaine Irving; Leah Sansbury; Maggie Tabberer; David Leather; Chris Compton
Journal:  ERJ Open Res       Date:  2019-11-04

3.  The Efficacy and Cost-Effectiveness of Umeclidinium/Vilanterol versus Tiotropium in Symptomatic Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Yinhua Gong; Chen Lin; Yifeng Jin; Rong Chen
Journal:  Can Respir J       Date:  2022-08-25       Impact factor: 2.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.